Spero Therapeutics Aktie
1,71
EUR
-0,11
EUR
-6,25
%
2,18
USD
-0,03
USD
-1,36
%
Werbung
Spero Therapeutics Aktie Analyse
| 09.02.18 | Spero Therapeutics Overweight | Cantor Fitzgerald | |
| 27.11.17 | Spero Therapeutics Outperform | Oppenheimer & Co. Inc. | |
| 27.11.17 | Spero Therapeutics Buy | Stifel, Nicolaus & Co., Inc. |
Werbung
Werbung